| SC 13G/A | 2024-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Mirum Pharmaceuticals, Inc. | 2,693,581 | 5.8% | EDGAR |
| SC 13G | 2024-02-13 | VANGUARD GROUP INC | Mirum Pharmaceuticals, Inc. | 2,476,244 | 5.3% | EDGAR |
| SC 13G | 2024-01-31 | BlackRock Inc. | Mirum Pharmaceuticals, Inc. | 2,532,642 | 5.4% | EDGAR |
| SC 13D/A | 2023-12-29 | New Enterprise Associates 16, L.P. | Mirum Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13G | 2023-09-18 | BIOTECHNOLOGY VALUE FUND L P | Mirum Pharmaceuticals, Inc. | 2,329,616 | 5.0% | EDGAR |
| SC 13D/A | 2023-09-05 | Frazier Life Sciences IX, L.P. | Mirum Pharmaceuticals, Inc. | 3,566,912 | 7.7% | EDGAR |
| SC 13D/A | 2023-06-23 | New Enterprise Associates 16, L.P. | Mirum Pharmaceuticals, Inc. | 2,186,243 | 5.8% | EDGAR |
| SC 13G/A | 2023-05-03 | Flynn James E | Mirum Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-04-14 | Frazier Life Sciences IX, L.P. | Mirum Pharmaceuticals, Inc. | 3,566,912 | 9.4% | EDGAR |
| SC 13G/A | 2023-03-08 | BlackRock Inc. | Mirum Pharmaceuticals, Inc. | 1,677,907 | 4.6% | EDGAR |
| SC 13G/A | 2023-02-14 | Rock Springs Capital Management LP | Mirum Pharmaceuticals, Inc. | 1,795,733 | 4.9% | EDGAR |
| SC 13G | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Mirum Pharmaceuticals, Inc. | 2,057,000 | 5.6% | EDGAR |
| SC 13G/A | 2023-02-10 | Flynn James E | Mirum Pharmaceuticals, Inc. | 2,032,335 | 5.5% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | Mirum Pharmaceuticals, Inc. | 2,136,677 | 5.8% | EDGAR |
| SC 13D/A | 2022-12-01 | RiverVest Venture Fund IV, L.P. | Mirum Pharmaceuticals, Inc. | 1,621,118 | 4.4% | EDGAR |
| SC 13G/A | 2022-09-12 | Flynn James E | Mirum Pharmaceuticals, Inc. | 2,032,335 | 5.5% | EDGAR |
| SC 13D/A | 2022-08-18 | Novo Holdings A/S | Mirum Pharmaceuticals, Inc. | 1,760,000 | 4.8% | EDGAR |
| SC 13D/A | 2022-08-16 | Frazier Life Sciences IX, L.P. | Mirum Pharmaceuticals, Inc. | 3,566,912 | 9.7% | EDGAR |
| SC 13D/A | 2022-08-02 | Novo Holdings A/S | Mirum Pharmaceuticals, Inc. | 1,889,127 | 5.9% | EDGAR |
| SC 13D/A | 2022-04-08 | Novo Holdings A/S | Mirum Pharmaceuticals, Inc. | 2,200,000 | 6.9% | EDGAR |